Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Change in Account Payables (2021 - 2026)

MoonLake Immunotherapeutics' Change in Account Payables history spans 6 years, with the latest figure at -$6.2 million for Q1 2026.

  • Quarterly Change in Account Payables fell 304.88% to -$6.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.4 million through Mar 2026, up 33.45% year-over-year, with the annual reading at $20.6 million for FY2025, 187.35% up from the prior year.
  • Change in Account Payables came in at -$6.2 million for Q1 2026, down from $4.3 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $8.2 million in Q3 2025 to a low of -$6.2 million in Q1 2026.
  • The 5-year median for Change in Account Payables is $1.6 million (2024), against an average of $1.3 million.
  • Year-over-year, Change in Account Payables plummeted 460.19% in 2023 and then skyrocketed 682.92% in 2024.
  • MoonLake Immunotherapeutics' Change in Account Payables stood at -$801281.0 in 2022, then plummeted by 95.53% to -$1.6 million in 2023, then decreased by 9.65% to -$1.7 million in 2024, then soared by 348.54% to $4.3 million in 2025, then tumbled by 244.57% to -$6.2 million in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Change in Account Payables are -$6.2 million (Q1 2026), $4.3 million (Q4 2025), and $8.2 million (Q3 2025).